OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study.

Mraz D, Hanke CW, Papel I, Beer K, Yoelin S, Weinkle S, Keaney T, Rohrich RJ, McCaskill R, Shimoga SV, Park GS, Tong W, Hopfinger R

Open source

DOI: 10.1097/prs.0000000000012629
Published: 2026 Jul 1
Container: Plastic and reconstructive surgery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/prs.0000000000012629,
  title = {OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study.},
  author = {Mraz D and Hanke CW and Papel I and Beer K and Yoelin S and Weinkle S and Keaney T and Rohrich RJ and McCaskill R and Shimoga SV and Park GS and Tong W and Hopfinger R},
  year = {2026},
  journal = {Plastic and reconstructive surgery},
  doi = {10.1097/prs.0000000000012629},
  url = {https://doi.org/10.1097/prs.0000000000012629}
}

RIS

TY  - JOUR
TI  - OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study.
AU  - Mraz D
AU  - Hanke CW
AU  - Papel I
AU  - Beer K
AU  - Yoelin S
AU  - Weinkle S
AU  - Keaney T
AU  - Rohrich RJ
AU  - McCaskill R
AU  - Shimoga SV
AU  - Park GS
AU  - Tong W
AU  - Hopfinger R
PY  - 2026
JO  - Plastic and reconstructive surgery
DO  - 10.1097/prs.0000000000012629
UR  - https://doi.org/10.1097/prs.0000000000012629
ER  -

APA

D, M., CW, H., I, P., K, B., S, Y., S, W., T, K., RJ, R., R, M., SV, S., GS, P., W, T., & R, H. (2026). OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study.. Plastic and reconstructive surgery. https://doi.org/10.1097/prs.0000000000012629

Source records

pubmed · retrieved 2026-09-27T00:00:16.140Z